The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
110815283 11081528 3 F 20160829 20150501 20160829 EXP NL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-025839 BRISTOL MYERS SQUIBB 0.00 F Y 0.00000 20160829 CN NL NL

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
110815283 11081528 1 I CISPLATIN. CISPLATIN 1 Intravenous (not otherwise specified) UNK U U 0
110815283 11081528 2 PS ETOPOSIDE. ETOPOSIDE 1 Intravenous (not otherwise specified) 2 COURSES WITH 3 WEEKS IN BETWEEN U U 18768
110815283 11081528 3 I DOXORUBICIN DOXORUBICIN 1 Intravenous (not otherwise specified) UNK MG/ML, UNK U U 0 INJECTION
110815283 11081528 4 I IFOSFAMIDE. IFOSFAMIDE 1 Intravenous (not otherwise specified) 2 COURSES WITH 3 WEEKS IN BETWEEN U U 0 INJECTION
110815283 11081528 5 I VINCRISTINE VINCRISTINE 1 Intravenous (not otherwise specified) 2 COURSES WITH 3 WEEKS IN BETWEEN U U 0 INJECTION
110815283 11081528 6 C FRAXIPARINE /01437701/ NADROPARIN CALCIUM 1 Intravenous (not otherwise specified) 2850 IU/ML, QD U U 0 2850 DF INJECTION QD
110815283 11081528 7 C MESNA. MESNA 1 Intravenous (not otherwise specified) 150 MG, QD U U 0 150 MG INJECTION QD
110815283 11081528 8 C ONDANSETRON ONDANSETRON 1 Intravenous (not otherwise specified) 8 MG, BID U U 0 8 MG INJECTION BID
110815283 11081528 9 C LYRICA PREGABALIN 1 Unknown 75 MG, BID U U 0 75 MG CAPSULE BID
110815283 11081528 10 C EMEND APREPITANT 1 Oral 80 MG QD PLUS A SINGLE DOSE OF 125MG U U 0 80 MG CAPSULE QD
110815283 11081528 11 C EMEND APREPITANT 1 Oral 80 MG QD PLUS A SINGLE DOSE OF 125MG U U 0 125 MG CAPSULE QD
110815283 11081528 12 C FENTANYL. FENTANYL 1 Transdermal 75 MCG/HR ONCE EVERY 3 DAYS U U 0 75 UG PATCH
110815283 11081528 13 C PARACETAMOL ACETAMINOPHEN 1 Unknown 1000 MG, TID U U 0 1000 MG SUPPOSITORY TID
110815283 11081528 14 C CLONIDINE. CLONIDINE 1 Unknown 75 ?G, BID U U 0 75 UG BID
110815283 11081528 15 C LORAZEPAM. LORAZEPAM 1 Unknown 1 MG, ONCE A DAY AS NEEDED U U 0 1 MG TABLET QD
110815283 11081528 16 C LACTULOSE. LACTULOSE 1 Oral 15 ML, BID U U 0 15 ML SYRUP BID
110815283 11081528 17 C DEXAMETHASONE. DEXAMETHASONE 1 Unknown UNK, PRN U U 0
110815283 11081528 18 C COLECALCIFEROL CHOLECALCIFEROL 1 Unknown 10 IU/ML, QD U U 0 10 DF DROP QD
110815283 11081528 19 C FUROSEMIDE. FUROSEMIDE 1 Intravenous (not otherwise specified) 10 MG, QD U U 0 10 MG INJECTION QD
110815283 11081528 20 C CYCLOPHOSPHAMIDE. CYCLOPHOSPHAMIDE 1 Unknown 2300 MG, ONE TIME DOSE U U 0 2300 MG
110815283 11081528 21 C OMEPRAZOLE. OMEPRAZOLE 1 Unknown 10 MG, QD U U 0 10 MG TABLET QD
110815283 11081528 22 SS ZOFRAN ONDANSETRON HYDROCHLORIDE 1 Oral 8 MG, BID U U 0 8 MG TABLET BID
110815283 11081528 23 C ABSTRAL FENTANYL CITRATE 1 Sublingual 200 ?G, PRN U U 0 200 UG TABLET

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
110815283 11081528 1 Ewing's sarcoma
110815283 11081528 2 Ewing's sarcoma
110815283 11081528 3 Ewing's sarcoma
110815283 11081528 4 Ewing's sarcoma
110815283 11081528 5 Ewing's sarcoma
110815283 11081528 6 Product used for unknown indication
110815283 11081528 7 Product used for unknown indication
110815283 11081528 8 Product used for unknown indication
110815283 11081528 9 Product used for unknown indication
110815283 11081528 10 Product used for unknown indication
110815283 11081528 12 Product used for unknown indication
110815283 11081528 13 Product used for unknown indication
110815283 11081528 14 Product used for unknown indication
110815283 11081528 15 Product used for unknown indication
110815283 11081528 16 Product used for unknown indication
110815283 11081528 17 Product used for unknown indication
110815283 11081528 18 Product used for unknown indication
110815283 11081528 19 Product used for unknown indication
110815283 11081528 20 Product used for unknown indication
110815283 11081528 21 Product used for unknown indication
110815283 11081528 22 Product used for unknown indication
110815283 11081528 23 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
110815283 11081528 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
110815283 11081528 Drug interaction
110815283 11081528 Malnutrition
110815283 11081528 Maternal exposure during pregnancy
110815283 11081528 Off label use
110815283 11081528 Sepsis
110815283 11081528 Weight decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
110815283 11081528 1 20150120 0
110815283 11081528 2 20150220 0
110815283 11081528 3 20150220 0
110815283 11081528 4 20150220 0
110815283 11081528 5 20150220 0